ASM Avino Silver And Gold Mines Ltd (delisted)

Representatives of ALDA Pharmaceuticals Corp. (TSX VENTURE:APH)(OTCBB:APCSF)
("the Company" or "ALDA") attended the 142nd Annual Spring Meeting ("ASM") of
the Ontario Dental Association ("ODA") on April 30 and May 1, 2009. This meeting
is the largest dental conference held in Canada and took place at the Metro
Toronto Convention Centre. Joining over 275 other exhibitors at the ASM, ALDA
presented its new product line to over 10,000 dentists and 25,000 dental staff.


The products on display included:

- T36(R) Disinfectant

- T36(R) Disinfectant Wipes

- T36(R) Antiseptic Hand Sanitizer Gel

- T36(R) Antiseptic Hand Sanitizer Wipes

- T36(R) Disinfectant Cleaner CONCENTRATE

All of the products attracted significant interest and a large number of samples
were provided to the attendees. The safety and efficacy of T36(R) Disinfectant
was of particular interest as was the ability of T36(R) Antiseptic Hand
Sanitizer to kill Norwalk-like viruses and to have a residual anti-microbial
effect, unlike typical alcohol-based hand sanitizers. As a result, T36(R)
Antiseptic Hand Sanitizer Gel and canisters holding 160 T36(R) Antiseptic Hand
Sanitizer Wipes were very popular. With the addition of T36(R) Disinfectant
Cleaner CONCENTRATE to the product line, the attendees recognized that ALDA's
products can satisfy all of their infection control needs.


Dr. Terrance Owen, President & CEO, states, "It was very gratifying to see such
a positive response to our products. Certainly this was enhanced by the concern
over H1N1, the so-called "swine flu". People were very surprised when, as a
demonstration of the safety of our products, we sprayed T36(R) Disinfectant
directly onto our hands. Everyone who tried T36(R) Antiseptic Hand Sanitizer
told us that they think it is superior to other comparable products and, when
they learned about the greater efficacy and residual effect, were even more
interested. We will now be working towards capitalizing on the enthusiasm
generated from this conference and commencing our marketing program as soon as
possible."


About ALDA Pharmaceuticals Corp.

ALDA is focused on the development of infection-control therapeutics derived
from its patented T36(R) technology. The company trades on the TSX Venture
Exchange under the symbol APH.


Terrance G. Owen, Ph.D., MBA, President & CEO

Cautionary Note Regarding Forward-looking Statements: Information in this press
release that involves ALDA's expectations, plans, intentions or strategies
regarding the future are forward-looking statements that are not facts and
involve a number of risks and uncertainties. ALDA generally uses words such as
"outlook", "will", "could", "would", "might", "remains", "to be", "plans",
"believes", "may", "expects", "intends", "anticipates", "estimate", "future",
"plan", "positioned", "potential", "project", "remain", "scheduled", "set to",
"subject to", "upcoming", and similar expressions to help identify
forward-looking statements. The forward-looking statements in this release are
based upon information available to ALDA as of the date of this release, and
ALDA assumes no obligation to update any such forward-looking statements.
Forward-looking statements believed to be true when made may ultimately prove to
be incorrect. These statements are not guarantees of the future performance of
ALDA and are subject to risks, uncertainties and other factors, some of which
are beyond its control and may cause actual results to differ materially from
current expectations.

Avino Silver & Gold Mines Ltd. (TSXV:ASM)
Historical Stock Chart
From Jun 2024 to Jul 2024

Avino Silver & Gold Mines Ltd. (TSXV:ASM)
Historical Stock Chart
From Jul 2023 to Jul 2024